Mainz Biomed B.V. (MYNZ)
NASDAQ:MYNZ
Holding MYNZ?
Track your performance easily

Mainz Biomed B.V. (MYNZ) Financial Statements

236 Followers

Mainz Biomed B.V. Financial Overview

Mainz Biomed B.V.'s market cap is currently ―. The company's EPS TTM is $-1.639; its P/E ratio is -0.17; Mainz Biomed B.V. is scheduled to report earnings on April 15, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Jun 22Dec 21Jun 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.07M$ 17.14M$ 26.01M$ 8.73M$ 195.16K
Total Assets$ 15.41M$ 20.24M$ 27.62M$ 10.04M$ 734.47K
Total Debt$ 6.39M$ 1.32M$ 2.49M$ 520.73K$ 675.88K
Net Debt$ -680.31K$ -15.82M$ -23.52M$ -8.21M$ 480.72K
Total Liabilities$ 12.16M$ 6.14M$ 3.84M$ 3.68M$ 3.15M
Stockholders Equity$ 3.25M$ -4.15M$ 23.77M$ -3.52M$ -2.41M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Mainz Biomed B.V. Earnings and Revenue History

Mainz Biomed B.V. Debt to Assets

Mainz Biomed B.V. Cash Flow

Mainz Biomed B.V. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis